glp-1 obesity drug news today september 15 2025 Alarming rise in weight loss overdoses Unpacking $100B+ Obesity Market Opportunity:
Description
The efficacy and safety of liraglutide added to metformin in patients with diabetes: A meta-analysis of randomized controlled trials
The damage disrupts the stomach's natural contractions needed to process and empty food
J Alzheimers Dis
38 A multicenter phase II study (EVIDENCE IV) comparing saroglitazar magnesium with placebo in NASH patients achieved the primary endpoint: improvement of hepatitis from baseline at 16 weeks and improvement of liver fat content measured by magnetic resonance imaging-proton density fat fraction
They require monitoring on a number of fronts and careful, regular follow-up after surgery
doi: 10.1016/j.jns.2016.10.052 41 DengW.SaxeM
